January is Cervical Cancer Awareness month, so for this podcast, we’ve collected the latest updates from our interviews with leading experts in cervical cancer. 

Dr Jamie Takayesu, MD, of the University of Michigan, Ann Arbor, MI, explains recent research into disparities in the assessment of sexual function of men and women undergoing radiotherapy for prostate cancer or cervical cancer. Professor Jyoti Mayadev, MD, of the University of California San Diego, San Diego, CA, takes us through the Phase III CALLA trial, which investigated durvalumab and chemoradiotherapy for cervical cancer. Finally, Dr Kamran Ahmed, MD, of Moffitt Cancer Center, Tampa, FL, explains interim results from a Phase II trial of atezolizumab and SBRT in advanced cervical cancer.